Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Not yet recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 2400Neoplasms 1819Carcinoma, Non-Small-Cell Lung 1599Prostatic Neoplasms 1298Colorectal Neoplasms 1140Lung Neoplasms 984Neoplasm Metastasis 830Multiple Myeloma 792Leukemia, Myeloid, Acute 767Ovarian Neoplasms 674Pancreatic Neoplasms 662Melanoma 660Squamous Cell Carcinoma of Head and Neck 586Carcinoma, Hepatocellular 567Recurrence 562Brain Neoplasms 527Glioblastoma 513Head and Neck Neoplasms 500Stomach Neoplasms 497Triple Negative Breast Neoplasms 465Lymphoma 454Uterine Cervical Neoplasms 450Carcinoma, Renal Cell 425Precursor Cell Lymphoblastic Leukemia-Lymphoma 410Lymphoma, Non-Hodgkin 389Endometrial Neoplasms 381Sarcoma 368Lymphoma, Follicular 356Urinary Bladder Neoplasms 354Hematologic Neoplasms 352

Interventions

Sevoflurane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Chalazion × 1 year × Clear all
NCT07496515 2026-03-27

CH01

Jaeb Center for Health Research

Phase 2 Not yet recruiting
168 enrolled

Chalazion

NCT07450495 2026-03-04

SEVO-PED

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

Phase NA Recruiting
80 enrolled

Chalazion

NCT07405138 2026-02-19

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Lumenis Be Ltd.

Phase NA Not yet recruiting
40 enrolled

Chalazion

NCT07039461 2026-01-06

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Lumenis Be Ltd.

Phase NA Terminated
4 enrolled

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡